Hemostemix Inc has seen a remarkable surge in its stock price, gaining over 33% in just one trading day.
In the latest trading session, Hemostemix Inc (HEM.V) experienced a striking increase, closing up 33.33% to CA$0.06. This significant uptick positions the company at a market cap of approximately CA$11.27 million, highlighting its potential in the biotech sector.
Advertisement
Hemostemix Inc
HEM.V
HEM.V
Hemostemix Inc
WealthAwesomeAdvertisement
Market cap
$13.32M
52W high
$0.14
52W low
$0.04
1W change
+15.38%
Beta
0.61
Analyst Price Targets
Based on analyst covering HEM
Wall Street analysts forecast HEM stock price to rise 1180.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.96
+1180.0% Upside
Current Price
C$0.07
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Advertisement
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on HEM's historical volatility
30-Day Vol
140.1%
Annualized
90-Day Vol
116.5%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$0.09
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.08 | C$0.05 – C$0.13 |
| 60 trading days | C$0.08 | C$0.04 – C$0.17 |
| 90 trading days | C$0.09 | C$0.04 – C$0.21 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors should consider the implications of this sudden price rise, especially in the context of Hemostemix's ongoing developments and market activity.
33.33% Gain in One Day
Hemostemix Inc's stock price jumped from CA$0.045 to CA$0.06 in a single trading session, reflecting heightened market interest.
Bull case
The recent price surge suggests that investors are becoming more confident in Hemostemix's future. As the company explores innovative stem cell therapies, this growing interest could indicate a positive outlook.
Bear case
However, it’s important to note that the price increase comes without substantial news or developments. This raises concerns about whether the rise can be maintained over the long term.
Market Reaction
Advertisement
The significant rise in Hemostemix's stock price has caught the attention of investors, suggesting a possible shift in market sentiment. With a market cap of CA$11.27 million, the company is still considered a small-cap player, which can lead to more volatile price movements.
Future Prospects
While the recent price increase is promising, potential investors should remain cautious. Hemostemix's future developments, particularly in stem cell therapy, will be critical in determining whether this upward trend can be sustained. For more insights on Hemostemix's journey, visit our stock page.
Understanding the Volatility
Small-cap stocks like Hemostemix often experience sharp price swings due to lower trading volumes and market interest. Investors should be prepared for potential fluctuations and consider the company's fundamentals before making investment decisions. For more information, check out our detailed analysis on HEM.V.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
